Patrick Walsh CEO of Anatomic is a career stem cell biologist with experience spanning more than 15 years across both academic and industrial positions. His graduate work from the University of Minnesota Stem Cell Institute involved early technology development in the field of cellular reprogramming toward pluripotency. Following graduation, Patrick translated this expertise to Lonza Walkersville's Pluripotent Stem Cell Innovation Center focusing on current good manufacturing practices (cGMP) -compliant stem cell culture systems and reprogramming, where he developed several commercialized technologies. Patrick subsequently returned to the University of Minnesota Stem Cell Institute to lay the groundwork for their cGMP-compliant production of induced pluripotent stem cells (iPSCs) and to learn about differentiation of iPSCs into ectodermal cell types. During this second project, Patrick discovered the technical origins underpinning the founding of Anatomic Incorporated, where his team is revolutionizing the rapid and efficient, stepwise directed differentiation of all cell types from pluripotent stem cells. Anatomic is most well known for its dorsal-root ganglia, trigeminal sensory, and dorsal horn neuronal platforms accelerating discovery in pain neurobiology.

Completing the Circuit: Advanced NAMs for Neurobiology and Beyond

Shaun is a graduate of the prestigious CIRM Bridges program focused on stem cell applications. He held a research position at NASA, followed by a small biotech company before pivoting to technical commercial roles. Always focused on bringing innovative solutions to scientists that aim to help patients.

Scalable iPSC-Derived Neural Models for HD-MEA and New Approach Methodologies (NAMs)